Make Sure Patients With Heavy Alcohol Use Don't Use Viberzi

September 2017

You'll hear about Viberzi (vye-BUR-zee, eluxadoline), a new Rx drug for irritable bowel syndrome with diarrhea (IBS-D).

IBS-D is hard to treat...management can be more art than science.

Viberzi is an opioid agonist that works primarily in the gut at usual doses...similar to loperamide (Imodium, etc).

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Influenza Help Patients Choose a Flu Vaccine for 2017/18 Season
Liver Disease Optimize Meds for Comorbidities in Nonalcoholic Fatty Liver Disease
Dermatology Tell Patients to Think of New Tattoos as Wounds
Neurology & Pain Consider Pros and Cons of Meds for Diabetic Peripheral Neuropathy
Hypertension Watch for Commonly Used Meds and Supplements That May Increase Blood Pressure
IBS Make Sure Patients With Heavy Alcohol Use Don't Use Viberzi
Cannabinoids Explain Risks and Benefits of Medical Marijuana
Multiple Sclerosis Reduce Side Effects of Multiple Sclerosis Meds
Storage & Disposal Don't Break the Cold Chain With Refrigerated and Frozen Meds
Women's Health Point Out Differences in Prenatal Vitamins to Pregnant Women
Anticoagulants Suggest a Low-Molecular-Weight Heparin for Cancer-Associated VTE
Dosage Forms Be Ready to Answer Questions About Chewable Tabs